Abstract: A molecular assembly comprising a host metal complex with a space formed therein, and compounds having substituents enclosed in the metal complex within the space and molecular chains bonded to the substituents and extending to the exterior of the metal complex, wherein two or more substituents are enclosed in the same space of the metal complex.

Abstract: Embodiments herein provide a nanoparticle, such as a metal nanoparticle, coupled to a linker molecule to form a nanoparticle-linker construct. In an embodiment, a nanoparticle-linker construct may be further bound to a substrate to take advantage of one or more properties of the nanoparticle. In an embodiment, a functionalized nanoparticle (a nanoparticle having a reactive functionality) may be bound to a linker to form a functionalized nanoparticle-linker construct which may in-turn be bound to a substrate.

Abstract: The present invention relates to a porphyrazine coloring matter or a salt thereof represented by the following formula (1): [wherein, the rings A to D are independently a benzene ring or a nitrogen-containing heteroaromatic ring, the number of the nitrogen-containing heteroaromatic ring is more than 0.00 and less than 1.00 as an average value, the rest are benzene rings, E is alkylene, X and Y are a sulfo-substituted anilino group and the like, b is 0.00 or more and less than 3.90 as an average value, c is 0.10 or more and less than 4.00 as an average value, and the sum of b and c is more than 3.00 and less than 4.00 as an average value].

Abstract: Compounds comprising a 2-phenylpyridine ligand further substituted with a heterocyclic group are provided. In particular, the compound comprises a 2-phenylpyridine ligand further substituted with a nitrogen-containing heterocycle. The compounds may be used in organic light emitting devices to provide devices having improved efficiency and lifetime.

Abstract: Coloring matters represented by general formula (1) or salts thereof are simply provided at a low cost as water-soluble coloring matters which exhibit absorption in the near-infrared region. Further, aqueous ink compositions which contain the coloring matters and have excellent storage stability are also provided. In general formula (1), Nc is optionally substituted naphthalocyanine; M is a metal oxide or the like; R1 and R2 are each independently hydrogen or the like; A is a crosslinking group; X and Y are each independently substituted arylamino or the like; k is more than 0 but up to 12 (on average); p is 0 to less than 12; the sum of k and p is more than 0 but up to 12; and any two or the three of R1, R2 and A may be united to form a ring.

Abstract: A polymeric compound containing a residue of a metal complex represented by formula (1) [wherein M represents a metal atom selected from ruthenium, rhodium, palladium, osmium, iridium and platinum; R1, R2, R3, R4, R5, R6 and R8 independently represent a hydrogen atom, a halogen atom, an alkyl group, or the like; m represents an integer of 1 to 3; n represents an integer of 0 to 2; Z1, Z2, Z3, Z4 and Z5 independently represent a carbon atom or a nitrogen atom, provided that at least two member of Z1, Z2, Z3, Z4 and Z5 represent a nitrogen atom, and when any one member of Z1, Z2, Z3, Z4 and Z5 represents a carbon atom, a hydrogen atom bound to the carbon atom may be substituted by a substituent; a moiety represented by formula (2) represents a bidentate monoanionic ligand; and Rx and Ry are atoms bound to the metal atom M and independently represent a carbon atom, an oxygen atom or a nitrogen atom] and a bivalent group.

Abstract: This invention relates to electroluminescent metal complexes of the formula (I), or (II), a process for their preparation, electronic devices comprising the metal complexes and their use in electronic devices, especially organic light emitting diodes (OLEDs), as oxygen sensitive indicators, as phosphorescent indicators in bioassays, and as catalysts.

Abstract: Compounds comprising phosphorescent metal complexes comprising cyclometallated imidazo[1,2-f]phenanthridine and diimidazo[1,2-a:1?,2?-c]quinazoline ligands, or isoelectronic or benzannulated analogs thereof, are described. Organic light emitting diode devices comprising these compounds are also described.

Abstract: The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I. Additionally, the present application provides pharmaceutical compositions containing at least one compound according to Formula I and optionally at least one additional therapeutic agent. Finally, the present application provides methods for treating a patient suffering from an MCHR-1 modulated disease or disorder such as, for example, obesity, diabetes, depression or anxiety by administration of a therapeutically effective dose of a compound according to Formula I where R1, R1a, R1b, A, R3, R4, R5, R5b and R6 are as defined herein.

Abstract: Chelating ligand precursors for the preparation of olefin methathesis catalysts are disclosed. The resulting catalysts are air stable monomeric species capable of promoting various methathesis reactions efficiently, which can be recovered from the reaction mixture and reused. Internal olefin compounds, specifically beta-substituted styrenes, are used as ligand precursors. Compared to terminal olefin compounds such as unsubstituted styrenes, the beta-substituted styrenes are easier and less costly to prepare, and more stable since they are less prone to spontaneous polymerization. Methods of preparing chelating-carbene methathesis catalysts without the use of CuCl are disclosed. This eliminates the need for CuCl by replacing it with organic acids, mineral acids, mild oxidants or even water, resulting in high yields of Hoveyda-type methathesis catalysts.

Abstract: A method of purification of a solid mixture of a metal-organic framework (MOF) material and an unwanted second material by disposing the solid mixture in a liquid separation medium having a density that lies between those of the wanted MOF material and the unwanted material, whereby the solid mixture separates by density differences into a fraction of wanted MOF material and another fraction of unwanted material.

Abstract: A method of modifying a particle that includes reacting a reactive compound having an X—[Y]n reactive group with a secondary compound N—S-ZM to form a substituted reactive intermediate [Y]a—X—(N—S-ZM)b, and reacting the particle with the substituted reactive intermediate [Y]a—X—(N—S-ZM)b to attach the substituted reactive intermediate to the surface of the particle to form a surface modified particle. The particle may comprise at least one of a dye particle, an inorganic pigment particle, an additive, or a combination thereof. X may be a sulfonyl, phosphoryl, or 1,3,5-triazinyl group. Y may be a halogen leaving group. N may be a nucleophilic group. S may be an organic group. ZM may be an ionizable end group. Also, n is an integer between 1 and 3, b is an integer between 1 and 3, and a=n?b. When n is equal to or greater than b, and wherein if b is 2 or 3, each N—S-ZM can be the same or different.

Abstract: A phosphorescent metal complex is provided, which comprises a metallic central atom M and at least one ligand coordinated by the metallic central atom M, wherein the one metallic central atom M and the ligand form a six-membered metallacyclic ring. Additionally specified are a radiation-emitting component comprising a metal complex, and a process for preparing the metal complex.

Abstract: An organic electroluminescent device comprising a pair of electrodes and at least one organic layer between the pair of electrodes, wherein the organic layer contains at least one compound represented by the formula (I), preferably by the formula (II) and more preferably by the formula (III) as defined herein.

Abstract: The present invention describes novel organometallic compounds which are phosphorescence emitters. Such compounds can, as active constituents (=functional materials), be used in a number of different applications, which in the broadest sense can be classed as belonging to the electronics industry. The compounds according to the invention are described by the formulas (I), (Ia), (II), (IIa), (III), (IIIa), (IV) and (IVa).

Abstract: Disclosed is a synthesis method for synthesizing in a short time and selectively a microcrystal of a polymer complex having three three-dimensionally and regularly arranged channels. Specifically disclosed is a synthesis method of a polymer complex crystal wherein (1) a metallic solution, which is a mixture of zinc halide(II) and a solvent A that can dissolve the zinc halide, is mixed with (2) a ligand solution, which is a mixture of a tridentate ligand that has three coordination sites coordinated to zinc of the zinc halide and a solvent B that can dissolve the tridentate ligand, to be a single-phase solution, thereby synthesizing a microcrystal of a polymer complex having a three-dimensional coordination network formed by coordinating the tridentate ligand to the zinc and having channels that are three-dimensionally and regularly arranged in the three-dimensional coordination network.

Abstract: The present invention relates to a compound according to Formula (I): A-(L-Y)p, wherein A comprises at least one substantially cell-membrane impermeable pendant group; L comprises any suitable linker and/or spacer group; Y comprises at least one arsenoxide or arsenoxide equivalent; p is an integer from 1 to 10; and the sum total of carbon atoms in A and L together, is greater than 6.

Abstract: The present invention relates to a cleavage agent and a cleavage method selectively acting on soluble assembly of amyloidogenic peptide or protein.

Abstract: An organic electroluminescent device, which has a pair of electrodes, and at least one organic layer including a luminescent layer between the electrodes, wherein the organic layer contains at least one compound of formula (I): wherein Q11 are atoms for forming a nitrogen-containing hetero ring; Z11 to Z13 each independently represents CR, wherein R represents a substituent, CH or N; n11 is 0 or 1; M11 is a metal or boron ion that may further have a ligand(s); and a compound of formula (6): wherein R63 to R66 each is a hydrogen atom or a substituent; X61 to X64 and Z61 to Z66 each is CR, wherein R represents a substituent, CH or N.

Abstract: The present invention provides an organic electroluminescent element having at least one organic layer including a luminescent layer between a pair of electrodes wherein at least one organic layer contains a metal complex of cyclic tetradentate ligand having a specific structure.

Abstract: A molecular assembly comprising a host metal complex with a space formed therein, and compounds having substituents enclosed in the metal complex within the space and molecular chains bonded to the substituents and extending to the exterior of the metal complex, wherein two or more substituents are enclosed in the same space of the metal complex.

Abstract: A composition includes a Group (VIII) transition metal, an anionic ligand bonded to the metal, a neutral electron donor ligand bonded to the metal, and an alkylidene group bonded to the metal. The alkylidene group includes a cycloaliphatic radical substituted with an ionic group. An associated method is also provided.

Abstract: A polymer substrate functionalized with a functionality comprising at least one cyclic, metal ion coordinating ligand group, the cyclic ligand group comprising at least 3 metal ion coordinating donor atoms independently selected from the group consisting of N, O and S.

Abstract: Process for the preparation of vulnerable oil wherein degummed and neutralized vulnerable oil is subjected to bleaching and thereafter subjected to filtration, characterized in that in the process one or more, preferably two or more, more preferably three or more and most preferably all four of the following steps a)-d) are included: a) bleaching involves both a wet step and a dry step; b) filtration is conducted in re-circulation until the filtrate has a turbidity of 0.2 FTU or less, preferably 0.1 FTU or less, before filtration of the vulnerable oil is commenced; c) after filtration the vulnerable oil is subjected to a second filtration to a turbidity of 0.1 FTU or less; d) the deodorization is conducted at a temperature of 190° C. or less until 5-20, preferably 8-20 m3 gas/kg oil is passed through the vulnerable oil.

Abstract: The present invention provides analogs of a Lysofylline (LSF), and synthetic methods for the preparation of such analogs. The have the active side chain moiety (5-R-hydroxyhexyl) of LSF and can have greater potency and oral bioavailability than LSF.

Abstract: The present invention relates to new substituted carboxylic acid amides of general formula wherein A, B and R1 to R5 are defined as in claim 1, the tautomers, the enantiomers, the diastereomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, which have valuable properties.

Abstract: The present invention provides a compound of formula I: or a pharmaceutically acceptable salt thereof. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compounds and compositions in the treatment of various protein kinase mediated disorders.

Abstract: The present invention provides a compound of formula I: or a pharmaceutically acceptable salt thereof. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compounds and compositions in the treatment of various protein kinase mediated disorders.

Abstract: The present invention is generally directed to electroluminescent Ir(III) complexes which have emission maxima in the red-orange to red region of the visible spectrum and devices that are made with the Ir(III) complexes.

Abstract: A light-emitting material comprises a compound having a partial structure represented by the following formulas (8), (20) and tautomers thereof: wherein the variables are as defined in the specification.

Abstract: This invention provides a quinolone derivative having potent antibacterial activity against various bacteria including drug-resistant strains which is a compound of the following formula wherein R1 is an optionally substituted aromatic group, a salt of the same or a hydrate of both.

Abstract: The present invention is generally directed to electroluminescent Pt(II) complexes which have emission maxima across the visible spectrum, and devices that are made with the Pt(II) complexes.

Abstract: The present invention provides a compound of formula I, or an N-oxide thereof or a pharmaceutically acceptable salt thereof: 1

Abstract: This invention provides compounds defined by Formula I 1

Abstract: Compounds of the following formula: 1

Abstract: The invention relates to novel substituted iminoazines of the general formula (I) 1

Abstract: The present invention provides a compound of formula I 1

Abstract: The present invention is directed in part towards methods of modulating the function of protein kinases with phenol- and hydroxynaphthalene-based compounds. The methods incorporate cells that express a protein kinase. In addition, the invention describes methods of preventing and treating protein kinase-related abnormal conditions in organisms with a compound identified by the invention. Furthermore, the invention pertains to phenol- and hydroxynaphthalene-based compounds and pharmaceutical compositions comprising these compounds.

Abstract: Complexes of a selected class of chiral ligands with molybdenum, tungsten or chromium, preferably molybdenum, are effective as catalysts in highly enantioselective and regioselective alkylation of allylic substrates.

Abstract: The present invention relates to compounds of the formula I, 1

Abstract: The present invention relates to 5-heteroatom-substituted pyrazoles of the formula I: 1

Abstract: A complex suitable for use as a catalyst in the polymerisation of olefins is disclosed, having the Formula (I) wherein M is a transition metal; X represents an atom or group covalently or ionically bonded to M; T is the oxidation state of M; b is the valency of the atom or group X; A1 to A3 are each independently N or P or CR, with the proviso that at least one but no more than two of them are independently CR; Y1 and Y2 are each independently CR′ or PR′R″; Z is oxygen or NR5, R5 and R7 and each R, each R′ and each R″ are independently selected from hydrogen, halogen, hydrocarbyl, substituted hydrocarbyl, heterohydrocarbyl, substituted heterohydrocarbyl or SiR303 where each R30 is independently selected from hydrogen, halogen, hydrocarbyl, substituted hydrocarbyl, heterohydrocarbyl and substituted heterohydrocarbyl; but excluding those complexes having the formulae (1) and (2) where in both cases R4 and R6 are Me, R5 and R7 are 2, 4, 6-trimethylphenyl, M is Fe, T is II, X is Cl a

Abstract: 3-Arylphenyl sulfide derivatives represented by general formula (I): 1

Abstract: Compounds of the formula I [LnMmXp]ZYq  (1) are claimed, where L is a ligand of the formula II and the individual symbols have the meanings defined in the description. The metal complexes are suitable as bleaching catalysts in detergents, cleaners and disinfectants which comprise peroxy compounds.

Abstract: Novel organic arsenic compounds are described as cytotoxic agents with potent anti-tumor activity against cancer cells and particularly, with regard to human leukemic cells and breast cancer cells.

Abstract: A process is disclosed for preparing acid amides, including isocyanate-functional 1,3,5-triazines and isocyanate-based 1,3,5 triazine derivatives, from the reaction of (Si, Ge or Sn substituted amino)-1,3,5 triazines and acid halides.

Abstract: The present invention provides reactive formazan dyestuffs of the general formula (I), Wherein A, B, D, Me, Q, R, and Z are defined in this document. The dyes according to the invention are distinguished by high fixation and a very good build-up. They are distinguished also by a low substantivity and a high exhaustion, and they have fiber-reactive properties and are very highly suitable for dyeing and printing of materials containing either cellulose fibers.

Abstract: A compound of the formula

Abstract: This invention relates generally to benzocycle-substituted pyrimidines and triazines and the use thereof to protect against degradation by environmental forces, inclusive of ultraviolet light, actinic radiation, oxidation, moisture, atmospheric pollutants and combinations thereof. The new class of benzocycle-substituted pyrimidines and triazines comprises a benzocycle attached to the triazine or pyrimidine ring, and preferably an additional aryl ring containing a hydroxyl group, either free or blocked to form a latent stabilizer, ortho- to the point of attachment to the triazine or pyrimidine ring. These materials may, under the appropriate circumstances, be bonded to formulations comprising coatings, polymers, resins, organic compounds and the like via reaction of the bondable functionality with the materials of the formulation. A method for stabilizing a material by incorporating such benzocycle-substituted pyrimidines and triazines is also disclosed.

Abstract: Organic complexes of vanadium are provided, having the general structure VL3, where V is vanadium(III) and L is a monoprotic bidentate ligand that forms a five-membered, unsaturated vanadium containing ring, having vanadium coordinating oxygen or sulfur ring heteroatoms, and where the vanadium containing ring is fused to a six-membered heterocyclic ring. Preferably L is a hydroxypyrone or a hydroxypyridinone. The complexes have a number of uses, including the treatment of elevated blood glucose and related disorders, treatment of proliferative disorders, etc.